CLPT
Price
$9.25
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
282.16M
6 days until earnings call
Intraday BUY SELL Signals
OPK
Price
$1.63
Change
+$0.03 (+1.87%)
Updated
Oct 22 closing price
Capitalization
1.22B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLPT vs OPK

CLPT vs OPK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLPT vs. OPK commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a StrongBuy and OPK is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CLPT with price predictions
Oct 22, 2026

CLPT's RSI Oscillator recovers from oversold territory

The RSI Oscillator for CLPT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 28 of the 34 cases the stock moved higher. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLPT advanced for three days, in 216 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

CLPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLPT as a result. In 82 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for CLPT turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 45 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

CLPT moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for CLPT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLPT's P/B Ratio (26.184) is slightly higher than the industry average of (2.874). P/E Ratio (-7.839) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (9.268) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. CLPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for OPK with price predictions
Oct 22, 2026

OPK in upward trend: price may jump up because it broke its lower Bollinger Band on October 06, 2026

OPK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 40 cases where OPK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OPK's RSI Oscillator exited the oversold zone, 22 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on OPK as a result. In 74 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for OPK just turned positive on October 19, 2026. Looking at past instances where OPK's MACD turned positive, the stock continued to rise in 33 of 41 cases over the following month. The odds of a continued upward trend are 80%.

OPK moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +8.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPK advanced for three days, in 160 of 215 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 95 of 141 cases where OPK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for OPK crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.027) is normal, around the industry mean (66.046). P/E Ratio (-23.286) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.134) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. OPK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

FUNDAMENTALS RATINGS
CLPT vs OPK: Fundamental Ratings
CLPT
OPK
OUTLOOK RATING
1..100
6228
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
8740
P/E GROWTH RATING
1..100
1481
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPT's Valuation (31) in the null industry is in the same range as OPK (31) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

CLPT's Profit vs Risk Rating (100) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

OPK's SMR Rating (92) in the Biotechnology industry is in the same range as CLPT (100) in the null industry. This means that OPK’s stock grew similarly to CLPT’s over the last 12 months.

OPK's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for CLPT (87) in the null industry. This means that OPK’s stock grew somewhat faster than CLPT’s over the last 12 months.

CLPT's P/E Growth Rating (14) in the null industry is significantly better than the same rating for OPK (81) in the Biotechnology industry. This means that CLPT’s stock grew significantly faster than OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTOPK
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
67%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CLPT: $9.25 vs. OPK: $1.63)
Brand notoriety: CLPT and OPK are both not notable
CLPT represents the Medical/Nursing Services, while OPK is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 67% vs. OPK: 66%
Market capitalization -- CLPT: $282.16M vs. OPK: $1.22B
CLPT [@Medical/Nursing Services] is valued at $282.16M. OPK’s [@Medical Specialties] market capitalization is $1.22B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Medical Specialties] industry is $21.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 2 FA rating(s) are green while OPK’s FA Score has 1 green FA rating(s).

  • CLPT’s FA Score: 2 green, 3 red.
  • OPK’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLPT and OPK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 4 TA indicator(s) are bullish while OPK’s TA Score has 7 bullish TA indicator(s).

  • CLPT’s TA Score: 4 bullish, 5 bearish.
  • OPK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, OPK is a better buy in the short-term than CLPT.

Price Growth

CLPT (@Medical/Nursing Services) experienced а -4.05% price change this week, while OPK (@Medical Specialties) price change was +1.24% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.

Reported Earning Dates

CLPT is expected to report earnings on Oct 28, 2026.

OPK is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-3.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
CLPT
Daily Signal:
Gain/Loss:
OPK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CLPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPT
1D Price
Change %
CLPT100%
N/A
ICUI - CLPT
57%
Loosely correlated
+4.66%
ISRG - CLPT
46%
Loosely correlated
+3.67%
A - CLPT
45%
Loosely correlated
-2.17%
NVST - CLPT
45%
Loosely correlated
+3.36%
SMTI - CLPT
43%
Loosely correlated
+0.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RNIN38.920.91
+2.40%
Bushido Capital US SMID Cap Equity ETF (RNIN)
DIV19.240.26
+1.37%
Global X SuperDividend US ETF (DIV)
EVNT12.27N/A
-0.02%
AltShares Event-Driven ETF (EVNT)
CORO35.34-0.56
-1.56%
iShares International Country Rotation Active ETF (CORO)
SOXY80.24-5.62
-6.54%
YieldMax Target 12 Semiconductor Option Income ETF (SOXY)